Pages that link to "Q36780922"
Jump to navigation
Jump to search
The following pages link to Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins (Q36780922):
Displaying 50 items.
- The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection (Q26864494) (← links)
- Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules (Q28741431) (← links)
- Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins (Q30708312) (← links)
- High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system (Q33281306) (← links)
- Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons (Q33592351) (← links)
- Advances in prevention of respiratory syncytial virus infections (Q33765654) (← links)
- Unusual antigenic and genetic characteristics of human respiratory syncytial viruses isolated in Cuba. (Q33784034) (← links)
- Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine (Q33793103) (← links)
- Respiratory syncytial virus genetic and antigenic diversity (Q33812405) (← links)
- Respiratory syncytial virus infections in infants affected by primary immunodeficiency. (Q33892605) (← links)
- Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion (Q33934074) (← links)
- Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector (Q34302198) (← links)
- Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. (Q34307704) (← links)
- Animal pneumoviruses: molecular genetics and pathogenesis (Q34313560) (← links)
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease (Q34330690) (← links)
- Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine (Q34464738) (← links)
- Molecular characterization of an outbreak of respiratory syncytial virus (subgroup A) in Havana, Cuba, by monoclonal antibodies and restriction mapping (N gene). (Q35231277) (← links)
- Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution? (Q35861139) (← links)
- Pediatric RSV infection during two winter seasons in British Columbia: A role for subgroup analysis in young children? (Q35893104) (← links)
- Novel antigens for RSV vaccines (Q36005960) (← links)
- Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation. (Q36128048) (← links)
- Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens (Q36155501) (← links)
- Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection (Q36438987) (← links)
- Identification of a variant subgroup A strain of respiratory syncytial virus (Q36540051) (← links)
- ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation. (Q36694038) (← links)
- Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus. (Q36913291) (← links)
- Vaccines against respiratory syncytial virus: The time has finally come (Q37018347) (← links)
- Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses. (Q37069783) (← links)
- Differentiation of respiratory syncytial virus subgroups with cDNA probes in a nucleic acid hybridization assay (Q37187290) (← links)
- Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development (Q37536191) (← links)
- Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. (Q38334591) (← links)
- Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions (Q38362415) (← links)
- Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity (Q38609801) (← links)
- Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection (Q38637248) (← links)
- Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection (Q38750689) (← links)
- Influence of respiratory syncytial virus strain differences on pathogenesis and immunity (Q39289416) (← links)
- Antigenic structure of human respiratory syncytial virus fusion glycoprotein. (Q39579940) (← links)
- Reduced innate immune response, apoptosis, and virus release in cells cured of respiratory syncytial virus persistent infection. (Q39629562) (← links)
- Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. (Q39695161) (← links)
- Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type (Q39864100) (← links)
- Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein (Q39869992) (← links)
- Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein (Q40041314) (← links)
- Oligo(A) sequences of human respiratory syncytial virus G protein gene: assessment of their genetic stability in frameshift mutants. (Q40041322) (← links)
- Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro (Q40042184) (← links)
- Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. (Q40065065) (← links)
- Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes (Q40067229) (← links)
- Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies (Q40101115) (← links)
- Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus (Q40107962) (← links)
- Phenotypic hiding: the carryover of mutations in RNA viruses as shown by detection of mar mutants in influenza virus (Q40116990) (← links)
- Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections. (Q40178284) (← links)